Concepedia

Misun Lee

ML

Statistics

Publications

32

Citations

3.6K

H-Index

22

Active since

2000

Affiliations

Astellas Pharma (United States)(Current)

Ulsan National Institute of Science and Technology

University of Groningen

Korea Advanced Institute of Science and Technology

Universitair Ziekenhuis Leuven

Misun Lee is an author at Astellas Pharma (United States) specializing in life sciences, medicine, and pharmacotherapy.

ORCID

Publications per year

2000–2023

32

Publications

32

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

Johan Maertens, Issam Raad, Kieren A. Marr et al. · The Lancet · 2015 · 972 citations

, , +17

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis

Francisco M. Marty, Luis Ostrosky‐Zeichner, Oliver A. Cornely et al. · The Lancet Infectious Diseases · 2016 · 694 citations

, , +15

Results of a Randomized Phase III Trial of Mirabegron in Patients with Overactive Bladder

Victor W. Νitti, Stephen M. Auerbach, Nancy Martin et al. · The Journal of Urology · 2012 · 368 citations

, , +17

Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study

Samuel Lederman, Faith D Ottery, Antonio Cano et al. · The Lancet · 2023 · 244 citations

, , +11

Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses

George R. Thompson, Adrián Rendón, Rodrigo Ribeiro dos Santos et al. · Clinical Infectious Diseases · 2016 · 215 citations · Full text

, , +17

1–5 of 32